OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
September 26, 2024 06:00 ET
|
OMEICOS Therapeutics GmbH
Interim data confirms OMT-28’s strong safety profile in PMD patients, top-line data expected mid-2025 BERLIN, GERMANY, September 26, 2024 – OMEICOS, a biopharmaceutical company developing...
pMD®️ Launches New Website Reflecting Shift to End-to-End Healthcare Solutions
September 01, 2022 15:00 ET
|
pMD
SAN FRANCISCO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- pMD®, a company that provides end-to-end solutions for health care providers and patients, announced they have launched a new public website that...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Psychemedics Corporation – PMD
February 27, 2017 18:05 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 27, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Psychemedics Corporation...
SocialCode and Moontoast Partner to Deliver Deeper Facebook Ad Engagement and ROI
March 25, 2013 09:00 ET
|
Moontoast
NASHVILLE, TN and BOSTON, MA--(Marketwire - Mar 25, 2013) - Moontoast, an innovative Social Rich Media advertising platform leader, today announced a partnership with SocialCode, the leading social...
Moontoast Wins Facebook Preferred Marketing Developer Innovation Competition
March 19, 2013 14:31 ET
|
Moontoast
NASHVILLE, TN and BOSTON, MA--(Marketwire - Mar 19, 2013) - Moontoast, a Facebook Preferred Marketing Developer (PMD), announced today that it has been named a winner in the Facebook PMD Innovation...
BNOTIONS Named Facebook Preferred Marketing Developer
April 19, 2012 09:59 ET
|
BNOTIONS
TORONTO, April 19, 2012 (GLOBE NEWSWIRE) -- BNOTIONS, a leading technology company specializing in Facebook, mobile and web application development, announced today it has been named a...
StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
February 10, 2010 09:00 ET
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient...